MedTrace Logo

Perinatal Opioid Use

NCT04049032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2024-09-19

No results posted yet for this study

Summary

To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine versus in-person.

Conditions

  • Opioid Use
  • Pregnancy

Interventions

BEHAVIORAL

In-Person Perinatal OUD Treatment

Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine as part of standard of care.

BEHAVIORAL

Perinatal OUD Treatment via Telemedicine

Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine as part of standard of care..

Sponsors & Collaborators

  • Medical University of South Carolina

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04049032 on ClinicalTrials.gov